Sven Gogov, MD, is an experienced global clinical development leader bringing over 15 years of pharmaceutical oncology experience and regulatory interactions to Nouscom.

Sven joined Nouscom in October 2021 as Vice President Clinical Development from Incyte where he served as Executive Director, Global Immuno-Oncology, responsible for developing the clinical strategy and trial execution for several assets targeting the tumor microenvironment.

Prior to Incyte, Sven held Senior Clinical Development positions in oncology at Novartis and OSI Pharmaceuticals, leading first in human and registrational studies for several successful European, US, Swiss and Asian filings. Sven began his career in the pharmaceutical industry at AstraZeneca as a Clinical Research Physician, previously holding an academic position in the Department of Medicine and Medical Oncology, University Health Network in Toronto, Canada.